Chase Brexton Health Services has formally announced the creation of a new clinical operations management team. This team officially took over corporate operations on Nov. 1, 2012. The Clinical ...
The Department of Medicine Clinical Leadership Team continues to grow in scope and expertise as we pursue our mission to provide exceptional patient care across the UAB enterprise. Each individual ...
Press Ganey and Prisma Health are integrating isolated workstreams into a cohesive system for managing complexity.
NEW YORK--(BUSINESS WIRE)--Medidata, a Dassault Systèmes company, announced technology enhancements that address key issues in clinical trial management and oversight. Enhancements to Medidata Detect ...
Healthcare providers receive data from many disparate sources: hospitals, doctors’ offices, labs and lab machines, medical devices, pharmacies, and more. Investment in the correct infrastructure to ...
FSU President Richard McCullough has tapped an experienced alumnus to help lead FSU Health as plans are in the making to buy ...
WALTHAM, Mass.--(BUSINESS WIRE)--Adagio Therapeutics, Inc., a company focused on the development of best-in-class antibodies to provide broad protection against SARS-CoV-2, SARS-CoV-1 and additional ...
Jeffrey E. Cehelsky, R.Ph., M.B.A. is the Senior Director of Clinical Operations for Alnylam Pharmaceuticals in Cambridge, MA. How did you choose your career? Was this an easy or hard process for you?
The Annual Outsourcing in Clinical Trials & Clinical Trial Supply Nordics 2025 conference will gather experts to discuss ...
DUBLIN, July 12, 2019 /PRNewswire/ -- The "Changing Paradigms in Clinical Trials: Market Landscape and Competitive Insights, 2019-2050" report has been added to ResearchAndMarkets.com's offering. The ...
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical ...
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today ...